Pharma & Biotech

What separates a promising biotech company from a true market leader? Halozyme Therapeutics is providing a compelling case study with...

A notable surge in Cabaletta Bio's stock price on Friday has captured investor attention, with shares climbing over 10%. The...

While major indices closed relatively flat on Friday, significant strategic developments were unfolding at Zimmer Biomet Holdings, Inc. The medical...

Celcuity Inc. saw its stock price climb to an unprecedented peak of $55.58 on Friday, cementing a remarkable year-to-date gain...

Iovance Biotherapeutics shares experienced a dramatic rally on Friday, closing the trading session with a substantial 13% gain at $2.49....

Shares of Viking Therapeutics experienced a dramatic sell-off after the biopharmaceutical company released Phase 2 trial results for its oral...

After an extended period of decline, Nurix Therapeutics Inc. shares demonstrated a significant resurgence, propelled by a substantial increase in...

TG Therapeutics is demonstrating extraordinary momentum, largely driven by the remarkable performance of its flagship therapy. While numerous pharmaceutical companies...

While Eli Lilly continues to dominate headlines with its blockbuster GLP-1 portfolio, a significant development is emerging from its oncology...

Genomics leader Illumina finds itself navigating a complex strategic landscape. The company's latest quarterly results reveal continued revenue pressure, even...